General MedicationsINJECTIONStandard
PRE-PEN
BENZYLPENICILLOYL POLYLYSINE
Standard Dose
60UMOLAR
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview PRE-PEN is listed in Drugs@FDA under application 050114 (BLA).
Review priority: STANDARD Marketing status: Prescription Active ingredient BENZYLPENICILLOYL POLYLYSINE Form and strength INJECTABLE;INJECTION - 60UMOLAR Sponsor ALLERQUEST Submission history Latest submission status date: 2023-01-18 00:00:00.
Structured Monograph
Clinical summary
Approval overview PRE-PEN is listed in Drugs@FDA under application 050114 (BLA). Review priority: STANDARD Marketing status: Prescription Active ingredient BENZYLPENICILLOYL POLYLYSINE Form and strength INJECTABLE;INJECTION - 60UMOLAR Sponsor ALLERQUEST Submission history Latest submission status date: 2023-01-18 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.